David J. Benjamin: What is important to individuals being treated for locally advanced/metastatic urothelial carcinoma

David J. Benjamin, Hematology-Oncology specialist, shared a post on X:

“Congratulations Andrea Apolo and colleagues on the latest publication in Patient Journal. With a growing armamentarium of therapies, it is critical for oncologists to understand what is important to individuals being treated for locally advanced/metastatic urothelial carcinoma.”

Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding

Authors: Andrea B. Apolo, Christine Michaels-Igbokwe, Nicholas I. Simon, David J. Benjamin, Mallory Farrar, Zsolt Hepp, Lisa Mucha, Sebastian Heidenreich, Katelyn Cutts, Nicolas Krucien, Natasha Ramachandran & John L. Gore

Source: David J. Benjamin/X